| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.04 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |